Protective Effects of COG133 on Carbon Tetrachloride‐Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Mutay Aslan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Akdeniz University Faculty of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Sphingolipids, Inflammation, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
Acute liver hepatotoxicity, characterised by inflammation, apoptosis and metabolic dysfunction, is often caused by drug‐induced toxic events. This study evaluated the protective effects of COG133, a synthetic peptide derived from apolipoprotein E (ApoE), against carbon tetrachloride (CCl 4 )‐induced liver damage, focusing on inflammation, apoptosis and sphingolipid metabolism. An acute hepatotoxicity model was established in rats utilising CCl 4 , with co‐administration of COG133 at varying doses. Histological analyses, immunostaining, messenger RNA (mRNA)/protein quantification, flow cytometry and mass spectrometry were employed to assess necroinflammation, apoptosis and sphingolipid levels. Cell viability assays and morphological evaluations were conducted on rat hepatocytes and hepatic stellate cells (HSC‐T6) to evaluate the protective effects of COG133. COG133 reduced liver damage, necroinflammation and apoptosis, restoring cell viability and lowering markers of inflammation, fibrosis and oxidative stress, including tumour necrosis factor‐alpha (TNF‐α), nuclear factor kappa‐B (NF‐κB), inducible nitric oxide synthase (NOS2), interleukin‐1 beta (IL‐1β), transforming growth factor‐beta (TGF‐β) and collagen type I (Col‐1). Immunostaining and molecular analyses confirmed these effects. Sphingomyelin (SM) and sphingosine‐1‐phosphate (S1P) levels were partially restored, while ceramide (CER) levels remained reduced in COG133‐treated groups. COG133 protects against CCl 4 ‐induced liver injury by reducing inflammation, apoptosis and morphological damage, with partial restoration of sphingolipid metabolism. These findings support its potential as a novel therapeutic agent for acute liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Akdeniz University Faculty of Medicine, Antalya, Turkey.
- Department of Medical Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Turkey.
- Department of Pathology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
ORCID-Profile: Mutay Aslan
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Aslan, M., Çırçırlı, B., Öztüzün, A., Tuzcu, H., Yılmaz, Ç., Çeker, T., & Elpek, G. Ö. (2025). Protective Effects of COG133 on Carbon Tetrachloride‐Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70677
Vancouver
Aslan M, Çırçırlı B, Öztüzün A, Tuzcu H, Yılmaz Ç, Çeker T, et al. Protective Effects of COG133 on Carbon Tetrachloride‐Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70677
BibTeX
@article{Aslan2025,
author = {Aslan, Mutay and Çırçırlı, Bürke and Öztüzün, Aleyna and Tuzcu, Hazal and Yılmaz, Çağatay and Çeker, Tuğçe and Elpek, Gülsüm Özlem},
title = {Protective Effects of COG133 on Carbon Tetrachloride‐Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70677}
}
EUVIMED